Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Viridian Therapeutics
VRDN
$2.13B
| $2.85M | ﹤0.01% |
125,397
+66,550
| +113% | +$1.09M |
|
2527
RingCentral
RNG
$4.81B
| $2.84M | ﹤0.01% |
89,824
+14,518
| +19% | +$459K |
|
2528
Stock Yards Bancorp
SYBT
$2.62B
| $2.84M | ﹤0.01% |
45,801
+26,537
| +138% | +$1.53M |
|
2529
Photronics
PLAB
$1.85B
| $2.83M | ﹤0.01% |
114,133
+85,397
| +297% | +$2.07M |
|
2530
Autoliv
ALV
$9.07B
| $2.82M | ﹤0.01% |
30,216
+8,859
| +41% | +$882K |
|
2531
FirstService
FSV
$6.61B
| $2.82M | ﹤0.01% |
15,450
-453
| -3% | -$77.9K |
|
|
MRUS
2532
PUT
DELISTED
Merus
MRUS
| $2.81M | ﹤0.01% |
+56,300
| New | +$2.94M |
|
2533
Madison Square Garden
MSGE
$3.64B
| $2.81M | ﹤0.01% |
66,045
+49,351
| +296% | +$1.93M |
|
2534
CALL
Joby Aviation
JOBY
$7.26B
| $2.8M | ﹤0.01% |
557,600
-500,000
| -47% | -$2.72M |
|
2535
B2Gold
BTG
$5.13B
| $2.8M | ﹤0.01% |
910,558
+174,477
| +24% | +$507K |
|
2536
The Greenbrier Companies
GBX
$1.54B
| $2.8M | ﹤0.01% |
55,084
+43,333
| +369% | +$2.07M |
|
2537
Idacorp
IDA
$8.32B
| $2.8M | ﹤0.01% |
27,184
+12,944
| +91% | +$1.29M |
|
2538
Ascendis Pharma A/S
ASND
$16B
| $2.8M | ﹤0.01% |
18,736
-268
| -1% | -$36.2K |
|
2539
CALL
Dropbox
DBX
$7.71B
| $2.8M | ﹤0.01% |
110,000
+42,000
| +62% | +$988K |
|
2540
ACM Research
ACMR
$5.43B
| $2.79M | ﹤0.01% |
137,584
+53,319
| +63% | +$1.02M |
|
|
DX
2541
Dynex Capital
DX
$3.15B
| $2.79M | ﹤0.01% |
218,853
+195,400
| +833% | +$2.41M |
|
2542
Global X Uranium ETF
URA
$5.66B
| $2.79M | ﹤0.01% |
97,590
-80,496
| -45% | -$2.16M |
|
2543
Americold
COLD
$4.03B
| $2.79M | ﹤0.01% |
98,739
+18,015
| +22% | +$515K |
|
2544
Nuvation Bio
NUVB
$2.14B
| $2.79M | ﹤0.01% |
1,218,321
-333,817
| -22% | -$1.02M |
|
2545
Sensata Technologies
ST
$6.81B
| $2.79M | ﹤0.01% |
77,759
+10,107
| +15% | +$376K |
|
2546
Mobileye
MBLY
$2.04B
| $2.79M | ﹤0.01% |
203,508
+177,156
| +672% | +$3.11M |
|
|
FBMS
2547
DELISTED
The First Bancshares, Inc.
FBMS
| $2.79M | ﹤0.01% |
86,748
+28,184
| +48% | +$873K |
|
2548
Perimeter Solutions
PRM
$4.98B
| $2.78M | ﹤0.01% |
206,967
+155,899
| +305% | +$1.61M |
|
2549
The GEO Group
GEO
$4.19B
| $2.78M | ﹤0.01% |
216,447
+170,839
| +375% | +$2.38M |
|
2550
CTS Corp
CTS
$1.86B
| $2.77M | ﹤0.01% |
57,238
+41,164
| +256% | +$2M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.